About Allianz BioInnovation
Allianz BioInnovation is a company based in Mumbai (India) founded in 2015 by Dhaval Mehta. It operates as a B2B. Allianz BioInnovation offers products and services including Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services. Allianz BioInnovation operates in a competitive market with competitors including Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
- Headquarter Mumbai, India
- Founders Dhaval Mehta
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website allianzbio.com
- Social LinkedIn X Facebook
- Legal Name Sard Biosciences Llp
- Date of Incorporation 23 Jan, 2020
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Allianz BioInnovation
Allianz BioInnovation operates through Sard Biosciences Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sard Biosciences Llp CIN AAR-6964 | Active | 23 Jan 2020 | Mumbai, Maharashtra | – | – | 5 | View details |
Products & Services of Allianz BioInnovation
Allianz BioInnovation offers a comprehensive portfolio of products and services, including Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services.
Reagents for molecular biology experiments and laboratory use
Proteins for COVID-19 testing and research applications
Cell lines for research and development purposes
Antibodies for diagnostic and analytical applications
Services for molecular biology and outsourcing needs
Board of directors of Sard Biosciences Llp (Allianz BioInnovation)
Sard Biosciences Llp is the primary company behind Allianz BioInnovation. The board of Sard Biosciences Llp currently have 5 directors; the longest-serving is Anwar Ahemad Khan, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anwar Ahemad Khan DIN 08676886 | Designated Partner | 23 Jan 2020 | 6 yrs 8 mo | Sard Biosciences Llp |
| Dhaval Ketan Mehta DIN 08671159 | Designated Partner | 23 Jan 2020 | 6 yrs 8 mo | Sard Biosciences Llp |
| Sanjay Solanki DIN 08671141 | Designated Partner | 23 Jan 2020 | 6 yrs 8 mo | Sard Biosciences Llp |
| Rushikesh Gajanan Kochrekar DIN 08671149 | Designated Partner | 23 Jan 2020 | 6 yrs 8 mo | Sard Biosciences Llp |
| Nikhat Jahan Anwar Ahmed Khan DIN 08676887 | Designated Partner | 23 Jan 2020 | 6 yrs 8 mo | Sard Biosciences Llp |
People of Allianz BioInnovation
1 people are tracked at Allianz BioInnovation (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Allianz BioInnovation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Allianz BioInnovation
Allianz BioInnovation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits | |
| cytivalifesciences.com | 1968 | Sheffield, United Kingdom | – | 578 | Life science software and research products are provided online. | |
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets |
Detailed competitors of Allianz BioInnovation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allianz Bioinnovation
Complete news archive for Allianz BioInnovation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Allianz BioInnovation
10 companies that operate in the same segment as Allianz BioInnovation (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Allianz BioInnovation
Allianz BioInnovation was founded in 2015.
Allianz BioInnovation is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Allianz Bioinnovation is a biotechnology company based in Mumbai, India, offering research products like molecular biology reagents, cell lines, and recombinant proteins. It provides diagnostic tools for vaccine development and COVID-19 testing, along with custom services for laboratories. The company serves clients in healthcare and research sectors through direct sales and support.
Allianz BioInnovation's top competitors include Abcam, Biocare Medical and Sino Biological.
Allianz BioInnovation offers Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services.
Allianz BioInnovation operates through Sard Biosciences Llp.
The legal entities of Allianz BioInnovation currently have 5 directors, including Anwar Ahemad Khan, Dhaval Ketan Mehta, Sanjay Solanki and others.